| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
|---|
|
| | | FI | | | Relfydess 150 units/ 1,5 ml | | PA | PA | k.A. | | Injektionslösung: Toxinum Botulinicum a (Stirpis I01) 150U. / 1.5ml | Ipsen Pharma Schweiz
GmbH | A | FB | | G |  |
| | | FI | | | Relfydess 150 units/ 1,5 ml | 10 | PA | PA | k.A. | | Injektionslösung: Toxinum Botulinicum a (Stirpis I01) 150U. / 1.5ml | Ipsen Pharma Schweiz
GmbH | A | FB | | G | |
| | | FI | | | Letybo 50 units | | PA | PA | k.A. | | Trockensubstanz: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U | Medius AG | A | FB | | G | |
| | | FI | | | Letybo 50 units | 2 | PA | PA | k.A. | | Trockensubstanz: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U | Medius AG | A | FB | | G | |
| | | FI | | | Letybo 50 units | 2 | PA | PA | k.A. | | Trockensubstanz: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U | Medius AG | A | FB | | G | |
| | | FI | | | Letybo 50 units | 6 | PA | PA | k.A. | | Trockensubstanz: Toxinum Botulinicum a (Stirpis Cbfc26) 50 U | Medius AG | A | FB | | G | |
| | | | | | Nuceiva 50 Units | | PA | PA | k.A. | | Trockensubstanz: Toxinum Botulinicum a (Stirpis Kcdc) 50 U | PLX Healthcare
Services (Schweiz)
GmbH | A | FB | | G | |
| L | | FI | | | Dysport 500U | Flasche(n) | 302.55 | 345.45 | 10% | | | Ipsen Pharma Schweiz
GmbH | A / SL | FB | | G | |
| L | | FI | | | Dysport 300U | Flasche(n) | 183.74 | 216.25 | 10% | | | Ipsen Pharma Schweiz
GmbH | A / SL | FB | | G | |
| L | | FI | | | Botox 50 Allergan-
Einheiten | | 201.70 | 235.80 | 10% | | Trockensubstanz: Toxinum Botulinicum A 50 U | AbbVie AG | A / SL | FB | | G | |
| L | | FI | | | Botox 100 Allergan-
Einheiten | Durchstechflasche(n) | 201.70 | 235.80 | 10% | | Trockensubstanz: Toxinum Botulinicum A 100 U | AbbVie AG | A / SL | FB | | G | |
| L | | FI | | | Botox 100 Allergan-
Einheiten | Durchstechflasche(n) | 403.40 | 455.15 | 10% | | Trockensubstanz: Toxinum Botulinicum A 100 U | AbbVie AG | A / SL | FB | | G | |
| L | | FI | | | Xeomin 50 LD50-Einheiten | Durchstechflasche(n) | 98.66 | 123.70 | 10% | | Trockensubstanz: Toxinum Botulinicum a (150 Kda) 50 UI | Merz Pharma (Schweiz) AG | A / SL | FB | | G | |
| L | | FI | | | Xeomin 100 LD50-Einheiten | Durchstechflasche(n) | 196.38 | 230.00 | 10% | | Trockensubstanz: Toxinum Botulinicum a (150 Kda) 100 UI | Merz Pharma (Schweiz) AG | A / SL | FB | | G | |
| | | FI | | | Alluzience | | PA | PA | k.A. | | | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | | | Alluzience | 2 | PA | PA | k.A. | | | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | | | Dysport 500U | 2 Flasche(n) | PA | PA | k.A. | | | Ipsen Pharma Schweiz
GmbH | A | FB | | G | |
| | | FI | | | Dysport 300U | 2 Flasche(n) | PA | PA | k.A. | | | Ipsen Pharma Schweiz
GmbH | A | FB | | G | |
| | | FI | | | Azzalure | Durchstechflasche(n) | PA | PA | k.A. | | | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | | | Azzalure | 2 Durchstechflasche(n) | PA | PA | k.A. | | | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | | | Bocouture 50 LD50-
Einheiten | Durchstechflasche(n) | PA | PA | k.A. | | Trockensubstanz: Toxinum Botulinicum a (150 Kda) 50 U | Merz Aesthetics
(Schweiz) AG | A | FB | | G | |
| | | FI | | | Bocouture 100 LD50-
Einheiten | | PA | PA | k.A. | | Trockensubstanz: Toxinum Botulinicum a (150 Kda) 100 U | Merz Aesthetics
(Schweiz) AG | A | FB | | G | |
| | | FI | | | Vistabel | Durchstechflasche(n) | PA | PA | k.A. | | Trockensubstanz: Toxinum Botulinicum A 100 U | AbbVie AG | A | FB | | G | |
| | | FI | | | Xeomin 200 LD50-Einheiten | | PA | PA | k.A. | | Trockensubstanz: Toxinum Botulinicum a (150 Kda) 200 UI | Merz Pharma (Schweiz) AG | A | FB | | G | |
